Lind Global Fund II LP - 30 Sep 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX)

Filing Manager
Lind Global Fund II LP
Reporting Manager
Lind Global Fund II LP
Security
TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol
TENX
Shares outstanding
5,028,182 shares
Disclosed Ownership
442,480 shares
Ownership
8.8%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:10:50 UTC
Date of event
30 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund II LP 8.8% 442,480 442,480 0 By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners II LLC 8.8% 442,480 442,480 0 /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 8.8% 442,480 442,480 0 /s/ Jeff Easton Jeff Easton